A major pharma company turned to Escalent to ensure its early-stage product pipeline remains robust. Working directly with the Innovation Lead, who documents, vets, and owns status reports for innovation ideas from the worldwide employee base, we set out to define a more efficient process for:
Escalent conducted a three-phase approach using desk research, idea lifecycle management, and disease landscaping.
To validate and shortlist key innovative ideas, we conducted scientific literature research, researched clinical trial information and provided medical device landscaping.
Next, we improved process efficiency and reporting capabilities through enhanced report visualization. This enabled visibility into advancement of innovative ideas throughout the multi-stage vetting process.
Lastly, we assessed market conditions and obtained novel and current competitive treatment options within the therapeutic areas to vet ideas for potential commercialization.
As a result of Escalent’s partnership, our client is now set up with: